Table 2.

Clinical characteristics of patients with and without MACE

	With MACE N = 148	Without MACE N = 804	P-value
Age, years	72 ± 9	66 ± 11	< 0.01
Age ≥ 65 years, n (%)	120 (81)	438 (54)	< 0.01
Male, n (%)	98 (66)	598 (74)	0.040
Current smoker, n (%)	29 (20)	131 (16)	0.32
Hypertension, n(%)	129 (87)	587 (73)	< 0.01
Diabetes mellitus, n (%)	86 (51)	260 (32)	< 0.01
Baseline lipid profile*
Total cholesterol, mmol/L	4.2 ± 1.1	4.0 ± 1.0	0.17
Triglyceride, mmol/L	1.5 ± 1.0	1.5 ± 1.0	0.71
HDL-C, mmol/L	1.2 ± 0.5	1.2 ± 0.3	0.51
LDL-C, mmol/L	2.2 ± 1.0	2.1 ± 0.8	0.13
LDL-C < 1.8 mmol/L, n (%)	56 (37.8)	303 (37.7)	0.97
Non-HDL-C, mmol/L	3.0 ± 1.1	2.8 ± 1.0	0.10
Follow-up lipid profile
Total cholesterol, mmol/L	3.7 ± 0.8	3.8 ± 0.8	0.17
Triglyceride, mmol/L	1.4 ± 0.9	1.4 ± 0.9	0.86
HDL-C, mmol/L	1.2 ± 0.4	1.2 ± 0.4	0.16
LDL-C, mmol/L	1.9 ± 0.7	1.9 ± 0.6	0.65
LDL-C < 1.8 mmol/L, n (%)	69 (46.6)	343 (42.7)	0.37
Non-HDL-C, mmol/L	2.5 ± 0.7	2.5 ± 0.7	0.45
Statin intolerance, n (%)	41 (27.7)	97 (12.1)	< 0.01
Ln hs-cTnI, pg/ml	3.1 ± 1.6	2.0 ± 1.2	< 0.01

*Baseline lipid profile was taken after the diagnosis of CAD was confirmed by coronary angiography

Abbreviations: HDL-C high density lipoprotein cholesterol, hs-cTnl high-sensitive cardiac troponin I, Ln natural logarithm, LDL-C low density lipoprotein cholesterol, MACE major adverse cardiovascular events